title: Cesium-associated hypokalemia successfully treated with amiloride.
abstract: Self-treatment of cancer with cesium chloride, despite proven lack of efficacy, continues to produce serious adverse effects. Among these is hypokalemia predisposing to life-threatening arrhythmia. The mechanism of cesium-associated hypokalemia (CAH) has not been described. We report urinary potassium wasting responsive to amiloride therapy in a cancer patient with CAH, and discuss possible mechanisms.
authors.affiliation: Beth Israel Deaconess Medical Center , Harvard Medical School , Boston, MA , USA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Horn
authors.affiliation: Beth Israel Deaconess Medical Center , Harvard Medical School , Boston, MA , USA.
authors.forename: Elliot
authors.initials: E
authors.lastname: Naidus
authors.affiliation: Beth Israel Deaconess Medical Center , Harvard Medical School , Boston, MA , USA.
authors.forename: Seth L
authors.initials: SL
authors.lastname: Alper
authors.affiliation: Beth Israel Deaconess Medical Center , Harvard Medical School , Boston, MA , USA.
authors.forename: John
authors.initials: J
authors.lastname: Danziger
keywords: cancer; cesium; hypokalemia